Not all bubbles in the bloodstream are detrimental. During the past decade, contrast-enhanced ultrasound has evolved from a purely investigational tool to a routine diagnostic technique. This transformation has been facilitated by advances in the microbubble contrast agents and contrast-specific ultrasound imaging techniques. The ability to non-invasively image molecular events with targeted microbubbles is likely to be important for characterizing pathophysiology and for developing new therapeutic strategies in the treatment of cardiovascular and neoplastic diseases.
|Original language||English (US)|
|Number of pages||6|
|Journal||Nature Reviews Drug Discovery|
|State||Published - Jun 1 2004|
ASJC Scopus subject areas
- Drug Discovery